Thermo Fisher Scientific to Present at 38th Annual J.P. Morgan Healthcare Conference on January 13, 2020

Jan. 03, 2020

WALTHAM, Mass., Jan. 3, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Monday, January 13, 2020, at 4:00 p.m. (PST) followed by a Q&A session at 4:30 p.m. (PST). 

You can access the webcast of the presentation and the Q&A session via the Investors section of our website, www.thermofisher.com.

About Thermo Fisher Scientific 

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with revenues of more than $24 billion and approximately 70,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.

Thermo Fisher Scientific (PRNewsfoto/Thermo Fisher Scientific)

Media Contact Information:
Ron O'Brien
Phone: 781-622-1242
E-mail: ron.obrien@thermofisher.com
Website: www.thermofisher.com

Investor Contact Information:
Ken Apicerno
Phone: 781-622-1294
E-mail: ken.apicerno@thermofisher.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/thermo-fisher-scientific-to-present-at-38th-annual-jp-morgan-healthcare-conference-on-january-13-2020-300980663.html

SOURCE Thermo Fisher Scientific

NYSE: TMO (Common Stock)

Investor Relations Kit

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue exceeding $25 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 75,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.

The world leader in serving science